Allied Market Research

Cerebral Thrombectomy Systems Market: Allied Market Research


Portland, OR -- (SBWIRE) -- 09/18/2017 -- Thrombectomy is a surgical procedure of removing thrombi (blood clots) from a blood vessel. The removal of a blood clot from brain is known as cerebral thrombectomy. Cerebral thrombectomy systems help remove blood clots from the brain. The blockage is caused due to an embolus, an atheromatous stenosis or a thrombus of one or more arteries.

Growth in incidences of chronic inflammatory diseases, sickle cell anemia, and kidney problems drive the market. However, high cost associated with the surgical procedures and less awareness among individuals impede the market growth. Moreover, R&D investments coupled with technological advancements in healthcare sector create lucrative opportunities for key market players in developing cost-efficient products.

Access Full Summary at:

The global cerebral thrombectomy systems market is segmented based on product type, utility, and geography. Based on product type, the market is divided into suction devices, catheters with balloons, snares, enveloping coil, rheolytic devices, and laser-based devices. Based on utility, it is bifurcated into reusable devices and disposable devices. Based on geography, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Request Report Sample:

Comprehensive competitive analysis and profiles of major market players, such as Terumo Corporation, Johnson and Johnson, Inc., Stryker Corporation, Vascular Solutions, Inc., Boston Scientific Corporation, Medtronic plc, Teleflex Incorporated, Penumbra Inc., The Spectranetics Corporation and AngioDynamics, Inc., are also provided in this report.

Cerebral Thrombectomy Systems Market Key Segments:
By Product Type

-Suction Devices
-Catheters with Balloons
-Enveloping Coil
-Rheolytic Devices
-Laser-Based Devices

By Utility

-Reusable Devices
-Disposable Devices